Cargando…
A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury: Retraction
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571727/ https://www.ncbi.nlm.nih.gov/pubmed/28816990 http://dx.doi.org/10.1097/MD.0000000000007871 |
Ejemplares similares
-
A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury
por: Li, Gang, et al.
Publicado: (2017) -
Botulinum toxin type A for neuropathic pain in patients with spinal cord injury
por: Han, Zee‐A, et al.
Publicado: (2016) -
Retraction: Botulinum Toxin for the Treatment of Hyperfunctional Lines of the Forehead
Publicado: (2017) -
Can Botulinum Toxin Type A effectively treat neuropathic pain in spinal cord injury?: A protocol of systematic review and meta-analysis
por: Wang, Zeng-mian, et al.
Publicado: (2020) -
Botulinum Toxin for Central Neuropathic Pain
por: Park, Jihye, et al.
Publicado: (2018)